Lemaitre Vascular (LMAT) Tops Q1 EPS by 2c; Guides Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
LeMaitre Q1 2023 Financial Results
May 2, 2023 4:05 PM EDTBURLINGTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q1 2023 results, announced a $0.14/share quarterly dividend and provided guidance.
Q1 2023 Financial ResultsÂ
Sales $47.1mm, +19% (+22% organic) vs. Q1 2022Op. income $7.9mm, -1%Op. margin 17%Net income $6.0mm, flatEarnings per diluted share $0.27, -1%Valvulotomes (+29%), carotid patches (+17%), bovine grafts (+22%), allografts (+42%) and... More
